This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
MYC targeting by OMO-103 in solid tumors: a phase 1 trial
Nature Medicine Open Access 06 February 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bernard, N.J. IL-17A heals wounds. Nat Immunol 23, 1134 (2022). https://doi.org/10.1038/s41590-022-01279-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-022-01279-y
This article is cited by
-
MYC targeting by OMO-103 in solid tumors: a phase 1 trial
Nature Medicine (2024)